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Abstract
Background: In culturing normal diploid cells, senescence may either happen naturally, in the form of replicative
senescence, or it may be a consequence of external challenges such as oxidative stress. Here we present a comparative
analysis aimed at reconstruction of molecular cascades specific for replicative (RS) and stressinduced senescence (SIPS) in
human fibroblasts.
Results: An involvement of caspase-3/keratin-18 pathway and serine/threonine kinase Aurora A/ MDM2 pathway was
shared between RS and SIPS. Moreover, stromelysin/MMP3 and N-acetylglucosaminyltransferase enzyme MGAT1, which
initiates the synthesis of hybrid and complex Nglycans, were identified as key orchestrating components in RS and SIPS,
respectively. In RS only, Aurora-B driven cell cycle signaling was deregulated in concert with the suppression of anabolic
branches of the fatty acids and estrogen metabolism. In SIPS, Aurora-B signaling is deprioritized, and the synthetic
branches of cholesterol metabolism are upregulated, rather than downregulated. Moreover, in SIPS, proteasome/ubiquitin
ligase pathways of protein degradation dominate the regulatory landscape. This picture indicates that SIPS proceeds in
cells that are actively fighting stress which facilitates premature senescence while failing to completely activate the orderly
program of RS. The promoters of genes differentially expressed in either RS or SIPS are unusually enriched by the binding
sites for homeobox family proteins, with particular emphasis on HMX1, IRX2, HDX and HOXC13. Additionally, we identified
Iroquois Homeobox 2 (IRX2) as a master regulator for the secretion of SPP1-encoded osteopontin, a stromal driver for
tumor growth that is overexpressed by both RS and SIPS fibroblasts. The latter supports the hypothesis that senescence-
specific de-repression of SPP1 aids in SIPS-dependent stromal activation.
Conclusions: Reanalysis of previously published experimental data is cost-effective approach for extraction of additional
insignts into the functioning of biological systems.
Background
All biological organisms share a universal feature called
aging. In multicellular organisms, the major consequence
of aging is a functional deficiency of cells, tissues and
organs. Additionally, renewable cells and tissues display
deficits in regenerative capacities that are paralleled by an
increase in incidence of hyperplasia, a gain-of-functional
change that allow cells to proliferate inappropriately [1].
The most serious type of hyperplasia is known as cancer.
In order to understand the aging process, model experi-
ments are of crucial importance. Majority of well-known
cellular models were developed at the time of the boom in
cell and tissue culturing, providing a trove of important
insights into cellular physiology. In particular, one of the
pioneers in cell culture, Leonard Hayflick, showed that
normal, non-transformed cells in culture can go through a
limited number of divisions upon reaching the end of their
replicative life span [2]. This finite number of divisions has
been termed as the Hayflick limit.
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Over the decades, it was discovered that proliferating
cells reach the Hayflick limit largely because repeated DNA
replication in the absence of telomerase causes telomeres
to shorten and eventually affect chromosomal stability and
genome functioning [3]. The cells undergoing replicative
senescence (RS) became enlarged in size and demonstrate
systemic changes in expression level of many genes. The
entry into the senescent state is mediated by at least two
distinct signaling cascades linked to the activation of two
tumor suppressing proteins, the p53/ p21 and p16INK4a/
pRB pathways [4]. On the other side, cells exposed to
various concentrations of different DNA damaging agents
such as bleomycin, tert-butylhydroperoxide, hydrogen
peroxide or doses of UV A and UV B also become post-
mitotic and display signs of senescence. Latter phenomenon
is termed as stress induced premature senescence (SIPS) [5].
The expression levels of many genes are changed during
SIPS. It is believed that cellular and molecular mechanisms
promoting an entry into senescence also provide protection
against tumor formation [6, 7]. Identification and under-
standing the differences between RS and SIPS senes-
cence is critical for the development of anti-aging
strategies that do not induce tumorigenesis.
The main purpose behind this study was to identify the
differentially expressed genes DEGs) that distinguish the
processes of replicative and stress induced senescence and
to reconstruct relevant molecular cascades. To this end,
we employed bioinformatics software platform GeneX-
plain that allowed both upstream and downstream ana-
lysis of DEGs validated by three-way comparisons of each
type of senescent cells against the young cells (control
group) and against each other. In both types of senescence,
master regulators genes were identified. We also identified
Iroquois Homeobox 2 (IRX2) as the master regulators for
an expression of SPP1-encoded osteopontin, a secreted
stromal driver for tumor growth that is overexpressed by
both RS and SIPS fibroblasts.
Methods
Microarray data, differential expression analysis
To investigate both types of senescence, publicly available
dataset GSE13330 was downloaded from Gene Expression
Omnibus (NCBI, Bethesda, MD, USA). This dataset is
comprised of 16 samples profiled using Affymetrix Human
Genome U133 Plus 2.0 Array. In this dataset, replicative-
senescent human foreskin BJ fibroblasts and young fibro-
blast controls were assayed in 6 biological replicates each.
An induction of cell senescence by stress was performed
with 100ug/ml of bleomycin sulfate, and analyzed in four
biological replicates [8].
Raw data of stress induced and replicative senescence as
well as data on younger control cells were normalized and
background corrected using RMA (Robust Multi-Array
Average). The Limma (Linear Models for Microarray
Data) method [9, 10] was applied to define fold changes
of genes and to calculate adjusted p-values using a
Benjamini-Hochberg adjusted p-value cutoff (.05). The up
regulated genes were filtered using the filter: logFC > 0.5
&& adj_P_Val < 0.05. Down regulated genes were filtered
using the filter: logFC < −0.5 && adj_P_Val < 0.05.
Functional enrichment analysis
DEGs were analyzed using geneXplain bioinformatics soft-
ware platform (http://www.genexplain.com). Using the work-
flows in geneXplain framework, the sets of up and down
regulated genes for both SIPS and RS were mapped to various
gene ontologies, i.e. biological processes, cellular components,
molecular functions, reactome pathways, TRANSPATH® [11]
pathways and transcription factor classification.
The output links each gene to GO identifiers that are, in
turn, are hyperlinked to the page http://www.ebi.ac.uk/
QuickGO with information about this ontological term.
Ontological classification evaluates statistical significance
for each term; the resultant p-values were used for further
interpretation of the results.
Promoter analysis
The sets of up- and down-regulated genes identified in each
comparison were subjected to the promoter analysis using
TRANSFAC [12] database of position weight matrices
(PWMs) characteristic for vertebrate genomes (vertebrate_
non_redundant_minSUM database subdivision). Each pro-
moter was defined as the sequence within −1000 to +100
coordinates, where the TSS of the main transcript of each
gene was the point 0.
The TFBS search on promoter sequences was done using
the MATCH algorithm [13, 14] integrated in the GeneX-
plain platform and executed within the pre-defined work-
flows. The promoter sequences and annotations of TSS
positions were accordinh to the Ensembl database (version
hg19 build 72.37).
Identification of master regulators
Lists of DEGs upregulated in each of cell senescence types
were used as inputs in a search for master regulatory key
molecules that influence the senescence pathways [13]. The
search was performed in the TRANSPATH® database
networks with a maximum radius of 10 steps upstream of
an input gene set, a default cut-off score at 0.2, and for FDR
at 0.05 and Z-score at 1.0.
Pathway studio -guided analysis of ospeopontin
regulation
To construct a concise network that bridges senescence
regulators highlighted by GeneXPlain–guided analysis of
DEGs, we used the Pathway Studio software (Elsevier,
Rockville, MD) that is able to dynamically create and draw
protein interaction networks and pathways. Each node
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represents either a molecular entity or a control mechan-
ism of the interaction. In this study, we the shortest path
analysis function was utilized predominantly.
Results
Extraction of gene signatures important in replicative
and stress-induced cell senescence was performed using
public 16-sample dataset GSE13330 previously described
in [8]. We divided the study in two parts. First, we
analyzed signaling events that are shared in both RS and
SIPS. Second, we identified DEGs and respective signal-
ing events uniquely describing each type of senescence.
To dissect the differences between RS and SIPS, 1) six
biological replicates of replicative senescent fibroblasts were
compared to six biological replicates of young fibroblasts
and yielded 1994 downregulated and 2818 upregulated
mRNAs; 2) four biological replicates of bleomycin induced
senescent fibroblasts were compared to six replicates of
young fibroblast cultures (3082 downregulated and 2768
upregulated mRNAs); 3) six biological replicates of replica-
tive senescent fibroblasts were compared to four biological
replicates of bleomycin induced senescent fibroblasts (2724
downregulated and 1628 upregulated mRNAs). Each list of
DEGs was divided into up- and downregulated sections. A
comparison of the three DEG lists that resulted from
comparisons described above have identified 524 shared
between RS and SIPS (Fig. 1a and b for downregulated
(N = 248) and upregulated (N = 242) genes, respectively).
All these mRNAs exhibited a change in expression levels of
more than two fold in all three types of the profiled cells.
Genes commonly involved in both bleomycin induced
and replicative senescence
A total of 1410 genes were upregulated and a total of
1291 genes were downregulated both in RS and SIPS as
compared to younger control fibroblasts. Resultant lists
of up- and downregulated genes were subjected to
functional analysis separately. Each gene was mapped
to GO biological processes, GO cellular components,
GO molecular functions, Reactome, HumanCyc, TF
classification and the latest TRANSPATH® [11] available
in the geneXplain platform.
Caspase-3/keratin-18 and Aurora A kinase/MDM2
pathways were the most upregulated signaling events
commonly dominating regulatory landscapes in both
bleomycin-induced and replicative type of senescence
(adjusted P-values < 0.009 for each of these signaling
events). Concerted upregulation of many enzymes par-
ticipating in glutamate (ABAT, GCLM, GLS), nucleotide
(PNP, NT5E, NAMPT, NMNAT2, AMPD3), polyamine
(ABT, ODC1) and choline (EPT1, PLCB4) metabolic
branches was also noted (adjusted p-value range of
<0.016 to < 0.05 for various fragments of these metabolic
cascades) (Table 1).
Among the most downregulated signaling events sig-
nificantly overrepresented in both bleomycin-induced
and replicative type of senescence were GluR/AMPA re-
ceptor (GRIA1 isoforms), wnt/beta-catenin (TCF7L2/
WNT2) and SDF-1 cascades (adjusted p-value range of
<0.026 to < 0.05 for various fragments of these signaling
pathways).
Upstream analysis aimed at identifying potential tran-
scription factor binding sites (TFBSs) overrepresented in
the promoters of differentially expressed genes com-
monly deregulated in both types of senescence was per-
formed after filtration of gene expression levels by log
fold change (FC) of 1.5 for up-regulated (N = 130 genes)
and down-regulated (N = 177) genes, separately. The
algorithm for transcription factor binding site (TFBS)
enrichment analysis has been described in Kel et al. [14].
Fig. 1 Venn diagrams depicting lists of downregulated (a) and upregulated (b) genes common and specific for each type of cell senescence.
Yellow circle represents the comparison of Bleomycin Treated cells to Replicative Senescent cells. Purple circle represents the comparison of
Bleomycin Treated cells to Young Controls. Blue circle represents the comparison of Replicative Senescent cells and Young Controls
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Table 1 Results of pathway fragment analysis
Pathway fragment analysis








Glu —GluR1:GluR3— > c-fos 2 11 0.11067 0.00504 0.02521 GRIA1 (ENSG00000155511),
GRIA1 (ENSG00000269977)
GluR1:GluR2 complex 2 9 0.09055 0.00334 0.02521 GRIA1 (ENSG00000155511),
GRIA1 (ENSG00000269977)
AMPA receptor signaling 2 14 0.14086 0.00819 0.0273 GRIA1 (ENSG00000155511),
GRIA1 (ENSG00000269977)
wnt — > beta-catenin 2 25 0.25153 0.02525 0.04864 TCF7L2, WNT2
SDF-1 — > G-protein 2 27 0.27165 0.02918 0.04864 CXCL12, GNG2
SDF-1 — > calcium mobilization 2 26 0.26159 0.02718 0.04864 CXCL12, GNG2
Pathway fragments up-regulated in both RS and SIPS
Caspase-3 —/ K18 2 3 0.04856 7.5719E-4 0.00909 CASP3, KRT18
Aurora-A(h) —/ p53(h) 2 3 0.04856 7.5719E-4 0.00909 AURKA, MDM2
glutamate metabolism 3 16 0.25897 0.00189 0.01513 ABAT, GCLM, GLS
L-glutamate —ammonia— > 2-oxoglutarate 2 8 0.12948 0.00671 0.01611 ABAT, GLS
xanthosine-5-phosphate — > allantoin 2 8 0.12948 0.00671 0.01611 NT5E, PNP
IMP — > xanthine 2 8 0.12948 0.00671 0.01611 NT5E, PNP
dGDP — > guanine 2 7 0.1133 0.00509 0.01611 NT5E, PNP
dADP — > hypoxanthine 2 7 0.1133 0.00509 0.01611 NT5E, PNP
L-ornithine — > succinate 2 8 0.12948 0.00671 0.01611 ABAT, ODC1
polyamine metabolism 2 8 0.12948 0.00671 0.01611 ABAT, ODC1
plasmenylethanolamine — > plasmenylcholine 2 10 0.16185 0.01057 0.02307 EPT1, PLCB4
GDP — > xanthine 2 12 0.19423 0.01519 0.03039 NT5E, PNP
interconversions and degradations of purine ribonucleotides
3 41 0.6636 0.02728 0.04365 AMPD3, NT5E, PNP
L-tryptophan — > NAD+, NADPH 2 16 0.25897 0.02653 0.04365 NAMPT, NMNAT2
biosynthesis and degradation of nicotinamide,NAD
+,NADP+
2 16 0.25897 0.02653 0.04365 NAMPT, NMNAT2
plasmenylcholine biosynthesis 2 19 0.30752 0.03667 0.05501 EPT1, PLCB4
Pathway fragments down-regulated in RS
acetyl-CoA, acetoacetyl-CoA — > cholesterol, fatty acid 7 21 0.90945 1.6325E-5 5.7683E-4 FDFT1, FDPS, HMGCS1, IDI1,
LSS, MVD, SQLE
cholesterol metabolism 7 21 0.90945 1.6325E-5 5.7683E-4 FDFT1, FDPS, HMGCS1, IDI1,
LSS, MVD, SQLE
biosynthesis of saturated and n - 9 series of MUFA and
PUFA
5 9 0.38976 1.5131E-5 5.7683E-4 ELOVL6, FADS1, FADS2, FASN,
SCD
17-alpha-hydroxyprogesterone — > 5alpha-
androstanediol
3 5 0.21654 7.3989E-4 0.01569 AKR1C1 (ENSG00000187134),
AKR1C2 (ENSG00000151632),
SRD5A3
acetyl-CoA, malonyl-CoA — > lignoceric acid 3 5 0.21654 7.3989E-4 0.01569 ELOVL6, FADS2, FASN
HMGCR regulation 9 65 2.81496 0.00158 0.02785 EGFR, FDFT1, FDPS, HMGCS1,
IDI1, INSIG1, LSS, MVD, SQLE
Pathway fragments up-regulated in RS
Aurora-B cell cycle regulation 17 55 4.09011 1.676E-7 4.0727E-5 BIRC5, BUB1, BUB1B, CCNB1,
CCNB2, CDC20, CDCA8, CDK1,
CENPE, CUL1, INCENP, MAD2L1,
PLK1, TTK, UBB, UBE2C, ZC3HC1
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Table 1 Results of pathway fragment analysis (Continued)
Cdk1, Plk1 —/ cyclin B 5 5 0.37183 2.1527E-6 1.7437E-4 CCNB1, CDC20, CDK1, CKS1B,
PLK1
Plk1 — > Bub1 5 5 0.37183 2.1527E-6 1.7437E-4 BUB1, CCNB1, CCNB2, CDK1,
PLK1
Plk1 — > INCENP 5 6 0.44619 1.2138E-5 7.3737E-4 CCNB1, CCNB2, CDK1, INCENP,
PLK1
Plk1 activation and substrates 9 24 1.78478 2.7847E-5 0.00135 BRCA2, CCNB1, CCNB2, CDK1,
KIF23, PLK1, PRKACB, RAD51,
STK10
CENP-E — > BubR1 5 7 0.52056 3.9925E-5 0.00162 BUB1, BUB1B, CENPE, MAD2L1,
TTK
cyclosome regulation 16 75 5.57743 7.6369E-5 0.00265 CCNA2, CCNB1, CCNB2, CDC20,
CDK1, CKS1B, CUL1, FBXO5,
MAD2L1, NDC80, PLK1, SKP2,
UBB, UBE2C, UBE2E2, UBE2S
cyclosome regulatory network 16 77 5.72616 1.0692E-4 0.00289 CCNA2, CCNB1, CCNB2, CDC20,
CDK1, CKS1B, CUL1, FBXO5,
MAD2L1, NDC80, PLK1, SKP2,
UBB, UBE2C, UBE2E2, UBE2S
Cdc20 ubiquitination 8 22 1.63605 1.03E-4 0.00289 BUB1B, CCNB1, CDC20, CDK1,
CKS1B, MAD2L1, UBB, UBE2C
Cdc20 deubiquitination 8 23 1.71041 1.4802E-4 0.0036 BUB1B, CCNB1, CDC20, CDK1,
CKS1B, MAD2L1, UBB, UBE2C
Plk1 cell cycle regulation 12 52 3.86702 2.8909E-4 0.00585 BRCA2, CCNB1, CCNB2, CDK1,
CUL1, FBXO5, KIF23, PLK1,
PRKACB, RAD51, STK10, UBB
Metaphase to Anaphase transition 12 52 3.86702 2.8909E-4 0.00585 BUB1, BUB1B, CCNB1, CDC20,
CDK1, CKS1B, FBXO5, MAD2L1,
NEK2, PLK1, UBB, UBE2C
Bub1 — > APC7 4 6 0.44619 3.9379E-4 0.00736 BUB1, BUB1B, CDC20, MAD2L1
S phase (Cdk2) 12 55 4.09011 5.0416E-4 0.00875 CCNA2, CDK1, CDKN3, CKS1B,
CUL1, E2F3, E2F8, PPM1A, PPM1B,
PPM1D, SKP2, UBB
ID complex deubiquitylation 4 7 0.52056 8.6562E-4 0.01402 CDK1, FANCD2, FANCI, UBB
borealin — > Aurora-B 3 4 0.29746 0.00153 0.02323 BIRC5, CDCA8, INCENP
Pin1 — > APP 3 5 0.37183 0.00361 0.05167 CCNB1, CCNB2, CDK1
Pathway fragments down-regulated in SIPS
No significant findings
Pathway fragments up-regulated in SIPS
HMGCR regulation 21 65 6.1986 1.9691E-7 6.4979E-5 CAB39, CAB39L, CYP51A1,
DHCR7, EGFR, FDFT1, FDPS,
HMGCS1, IDI1, LIPA, PSMA7,
PSMC1, PSMC4, PSMC5,
PSMD11, PSMD2, PSMD8, SC5D,
TM7SF2, UFD1L, VCP
acetyl-CoA, acetoacetyl-CoA — > cholesterol, fatty acid 9 21 2.00262 5.8742E-5 0.00646 CYP51A1, DHCR7, FDFT1, FDPS,
HMGCS1, IDI1, LIPA, SC5D,
TM7SF2
cholesterol metabolism 9 21 2.00262 5.8742E-5 0.00646 CYP51A1, DHCR7, FDFT1, FDPS,
HMGCS1, IDI1, LIPA, SC5D,
TM7SF2
parkin associated pathways 15 65 6.1986 8.2044E-4 0.03437 CALM2, DNAJA1, HSPA8, PSMA7,
PSMC1, PSMC4, PSMC5, PSMD11,
PSMD2, PSMD8, TUBA1C, TUBB6,
UBE2G1, UBE2L3, UBE2N
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The outputs shown in Additional files 1 and 2 include
the matrices of the hits which are over-represented in
the Yes track (study set) versus the No track (back-
ground set), with only the overrepresented matrices with
Yes-No ratio higher than 1 included, and the highest
Yes-No ratios reflecting higher degrees of matches en-
richment for the respective matrix in the Yes set. Matrix
cut-off value were calculated and associated with the P-
value score of enrichment as described before [14, 15].
Four homeobox genes, namely IRX2, HMX1, HDH,
HOXC13 were binders for Top sites enriched in genes
overexpressed in both bleomycin induced and replicative
senescence phenotypes, while HOXB13, MAZ, GKLF,
GLI, IK, SP1, PLZF, PBX were among transcription
factors that preferentially bind to the sites located in
genes downregulated both in RS and in SIPS.
Genes uniquely involved in replicative senescence
A total of 1408 genes were upregulated and a total of
703 genes were downregulated in replicative senescence,
but not in bleomycin induced senescence as compared
to younger control fibroblasts. Functional analysis was
performed for the lists of up- and downregulated genes
separately, as described before.
The list of the signaling events significantly overrepre-
sented in replicative senescence, but not in bleomycin
induced senescence was represented entirely by various
fragments of cyclosome regulatory network (adjusted p-
values range of <4.1e-5 to < 0.023), with Top overrepre-
sented being Aurora-B cell cycle regulation. The list of
most significantly downregulated fragments centered
around fatty acid anabolism, with an emphasis on bio-
synthesis of n-9 MUFAs and PUFAs, cholesterol metab-
olism and biosynthesis of estrogens (adjusted p-value
range of <5.8e-4 to < 0.028).
Upstream analysis aimed at identifying potential TFBSs
overrepresented in the promoters of differentially expressed
genes uniquely deregulated in replicative senescence was
performed after filtration of gene expression levels by log
fold change (FC) of 1.5 for up-regulated (N = 1408 genes)
and down-regulated (N = 703) genes, separately.
The outputs are shown in Additional files 3 and 4.
Interestingly, lists of putative transcription factor candi-
dates for being positive drivers for replicative senescence
was very similar to that driving both types of senescence.
In particular, homeobox genes IRX2, HMX1, HOXB13,
HOXC13 (p-values range of E-39 to < E-25) were among
Top positive regulators of replicative senescence. The
only non-homeobox positive regulator identified at
similar levels of confidence was promyelocytic leukemia
zinc finger PLZF (e-31). Transcription factors HOXB13,
IRX2, PLZF, HDX, DUXL, CDX2 and CPXH were
among these that significantly preferred to bind pro-
moters of genes downregulated in replicative senescence
(p-values range of E-23 to < E-12).
Genes uniquely involved in bleomycin-induced
senescence
A total of 1358 genes were upregulated and a total of
1791 genes were downregulated in bleomycin induced,
Table 1 Results of pathway fragment analysis (Continued)
Mdm2 — > p/CAF 8 23 2.19335 8.3317E-4 0.03437 PSMA7, PSMC1, PSMC4, PSMC5,
PSMD11, PSMD2, PSMD8, TAF9
(ENSG00000085231)
HMGCR — > 26S proteasome 9 28 2.67017 7.5931E-4 0.03437 PSMA7, PSMC1, PSMC4, PSMC5,
PSMD11, PSMD2, PSMD8,
UFD1L, VCP




cofilin-1 degradation 8 22 2.09799 5.9124E-4 0.03437 CFL1, PSMA7, PSMC1, PSMC4,
PSMC5, PSMD11, PSMD2,
PSMD8
Smac —/ cIAP-2 8 24 2.28871 0.00115 0.03446 BIRC3, PSMA7, PSMC1, PSMC4,
PSMC5, PSMD11, PSMD2, PSMD8
E1 —/ alpha-synuclein 8 24 2.28871 0.00115 0.03446 PSMA7, PSMC1, PSMC4, PSMC5,
PSMD11, PSMD2, PSMD8, UBE2L3
NIK degradation 8 24 2.28871 0.00115 0.03446 PSMA7, PSMC1, PSMC4, PSMC5,
PSMD11, PSMD2, PSMD8, TRAF3
Caspase network 17 82 7.81977 0.00137 0.03759 BID, BIRC3, CDC42, CFLAR,
CRADD, DFFA, HSPD1, MCL1,
PSMA7, PSMC1, PSMC4, PSMC5,
PSMD11, PSMD2, PSMD8,
UBE2L3, XIAP
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but not in replicative senescence as compared to youn-
ger control fibroblasts. Functional analysis was
performed for the lists of up- and downregulated genes
separately, as described before.
The signaling event significantly overrepresented in
bleomycin induced, but not in replicative senescence
was HMGCR regulation (adjusted p-value <6.5e−5),
followed by two cholesterol biosynthesis network
fragments (adjusted p-values <0.006 for each event eval-
uated separately), and a number of events with the
participation of proteasome or ubiquitin ligases (adjusted
p-values range of < 0.03 for each separate event).
Upstream analysis aimed at identifying potential
TFBSs overrepresented in the promoters of differentially
expressed genes uniquely up-regulated (N = 1358 genes)
and down-regulated (N = 1791) genes in bleomycin-
induced senescence was performed similarly to that for
the genes deregulated in replicative senescence.
The outputs are shown in Additional files 5 and 6. List
of putative transcription factor candidates for genes with
increased expression in bleomycin-induced senescence
included homeobox genes IRX2, CPHX and HDX as
well as other types of transcriptional factors, namely
Helios, RelA and HNF3B (p-values range of E-10 to < E-8).
A list of transcription factor bindings sites in overrepre-
sented genes downregulated in bleomycin induced senes-
cence were MAZ (E-13) and GKLF (E-12).
Master regulators orchestrating replicative and
bleomycin-induced senescence
An analysis of DEGs upregulated in RS and in SIPS identi-
fied stromelysin and MGAT1 as master regulator molecules
that influence the replicative senescence and bleomycin–in-
duced senescence expression programs, respectively.
Bridging senescence regulators to ospeopontin secretion
In their previous publication, Pazolli et al. [8] identified
SPP1-encoded osteopontin as a secreted driver for
tumor cells growth that is provided by senescent fibro-
blast. To understand how senescence-wide targets
highlighted by microarray analysis of senescent fibro-
blasts results in an increase in osteopontin secretion, a
concise network was constructed using Shortest Path
function in Pathway Studio software (Fig. 2). Iroquois
Homeobox 2 (IRX2) and POU4F1 were highlighted as
most plausible connecting signaling molecules.
Discussion
Over past decade, transcriptome profiling efforts that
employ either microarray or RNAseq have already
generated enormous amounts of data, with respective
data analysis often only scratching the surface [16, 17].
In many cases, high-quality datasets are generated to in-
vestigate specific hypothesis, and consequently, these
datasets get analyzed in a particular way. At least in
theory, the study design of these narrow-set, but
technically sound experiments should allow extraction
of additional information that could remain unrecovered
at the moment that the main manuscript gets sent to
the publishers [18].
In their 2009 paper, Pazolli et al. started to investigate
the mechanisms of the manner in which senescent BJ fi-
broblasts stimulate the growth of preneoplastic cells in
vitro and in vivo [8]. In their experiments, replicative
senescent (RS) and stress-induced premature senescent
(SIPS) fibroblasts were equally proficient at inducing the
growth of HaCaT cells. Their study of fibroblasts/HaCaT
xenografts in vivo arrived essentially at same results [8].
The authors subsequently hypothesized that growth-
promoting activities of both types of senescent cells are
maintained by a common core of genes. Based on that
hypothesis, they embarked on microarray-driven dissec-
tion of secreted factors commonly produced by RS and
SIPS fibroblasts. After a set of validation experiments in
qRT-PCR and in-cell cultures, soluble protein osteopon-
tin was highlighted as the protein of functional import-
ance, and its gene, SPP1, was identified as a master
regulator of a cancer niche environment [8]. An object-
ive of the study achieved; however, the microarray data-
set never got analyzed in larger context, i.e. for the
purpose of direct comparison between RS and SIPS
drivers.
In this study, we used the dataset of Pazolli et al., 2009
to extract the differentially expressed genes (DEGs) that
differentiate the processes of RS and SIPS, to reconstruct
relevant molecular cascades and to gain additional in-
sights into popular cellular model of bleomycin induced
senescence. Analysis of signaling events indicated that
an involvement of caspase-3/keratin-18 pathway that is
indicative of apoptotic rather than necrotic cell death
[19] and an evolutionarily conserved serine/threonine
kinase Aurora A/ MDM2 pathway essential for mitotic
progression [20] was shared between both types of sen-
escence. Observed upregulation of Aurora A is consist-
ent with previously demonstrated increase in a number
of aneuploid cells observed in ageing fibroblast cultures
[21]. Our analysis also highlighted concerted alteration
of glutamate, polyamine and choline metabolisms as well
as wnt/β-catenin and SDF-1/CXCL12 cascades. All these
findings are generally consistent with previous studies of
various ageing fibroblasts both in culture and in human
cohorts [22–24]. This consistency prompts us to stress
on the high quality of the dataset of Pazolli et al., 2009
being analyzed.
An analysis aimed at identifying master regulator
molecules that influence the replicative senescence and
bleomycin–induced senescence expression programs, pointed
at stromelysin/MMP3 and N-acetylglucosaminyltransferase
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Fig. 2 Hierarchically compiled output of an analysis for master regulators orchestrating gene expression program executed in replicative
senescence. Stromelysin, the master regulator of this network, is highlighted in red, intermediate controllers that are added by GeneXPlain
algorithm, a subset of input molecules is highlighted in blue. The intensity of the pink/red bars on a side of the molecule box represents the
degree of overexpression for respective genes
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enzyme MGAT1 that initiates the synthesis of hybrid and
complex N-glycans as key orchestrating components in
replicative senescence and in bleomycin-induced senescence,
respectively (Fig. 2 and Additional file 7). Traditionally,
MMP3 is seen as end-point biomarker or effector molecule
associated with ageing in fibroblasts. However, in
Hutchinson-Gilford progeria syndrome, there is a progressive
loss of MMP3 mRNA and protein expression [25]. Another
study linked carrier status forMMP3 6A (rs3025058) allele to
skin and lung aging [26]. Moreover, an exposure to MMP3
stimulates expression of Rac1b, a tumor-associated protein
with cell-transforming properties that aids in bypassing
replicative senescence [27] while driving motility and protu-
morigenic responses of the stroma [28]. Hence, there is an
accumulation of evidence that stresses on an importance of
MMP3 as a molecule of importance in replicative senescence
that deserves additional investigations. An identification of
MGAT1 that controls the synthesis the complex N-glycan
sugars in the Golgi as the key regulator of SIPS is even more
intriguing as there is strong associations between human
plasma N-glycans and age [29, 30].
Specific question that we aimed to dissect was on the
differences of the senescence programs executed in SIPS
and RS. Indeed, our analysis showed that in RS fibro-
blasts, the list Top deregulated events is populated by
fragments of Aurora-B driven cell cycle signaling that
are accompanied by the suppression of anabolic
branches of the fatty acids and estrogen metabolism.
This may be interpreted as an execution of ordered sen-
escence program that proceeds along with shutting
down the metabolism on a way to the halt of mitotic
progression and apoptosis that is being upregulated in
both RS and SIPS. On the other end, in bleomycin ex-
posed fibroblasts, Aurora-B signaling is deprioritized
and the synthetic branches of cholesterol metabolism
are upregulated, rather than downregulated, while
proteasome/ ubiquitin ligase pathways of protein deg-
radation are dominating the regulatory landscape. This
picture is indicative that the cells are going down ac-
tively fighting overwhelming amounts of stress that is
facilitating premature senescence of cells, but fail to
completely activate orderly program of replicative senes-
cence. Latter observation is consistent with activation of
26S proteasome and enhanced protein polyubiquitination
previously observed in both idiopathic and bleomycin-
induced pulmonary fibrosis [31]. Generalized mechanistic
depiction of cellular processes common and differentiating
RA and SIPS is presented at Fig. 2.
The list of the transcription factors capable of binding
within the promoter regions of the genes that change
their expression in either RS or SIPS was unusually
enriched by the members of homeobox family, with par-
ticular emphasis on HMX1, IRX2, HDX and HOXC13.
The possibility of an involvement of homeobox genes in
ageing has been proposed earlier [32], with many
homeobox containing TFs included in manually curated
GenAge reference database [33]. Our findings indicate
that the senescent program may be orchestrated by
transcription factors (TFs) of Homeobox family at least
in case of replicative senescence in vitro. On the other
hand, promoters of genes that change their expression
in bleomycin-induced senescence but not in replicatively
senescent fibroblasts were enriched by binding sites for
transcription factors Ikaros, RelA, HNF3B, GKLF and
MAZ. Both RelA and GKLF are known stress-induced
transcription regulators. RelA is the central player in the
classical (or canonical) pathway of induction of NF-κB
subunits that promotes senescence when activated in
human lung fibroblasts exposed to ROS [34]. GKLF-
deficient fibroblasts exposed to excessive levels of react-
ive oxygen species are more prone to become prema-
turely senescent than normal fibroblasts [35]. Moreover,
yet another transcription factor, HNF3B/FOXA2 is epi-
genetically silenced in peroxide-stressed fibroblasts [36],
therefore, an enrichment for binding sites for this factor
in transcripts downregulated in bleomycin induced sen-
escence is not surprising.
SPP1-encoded osteopontin, a secreted stromal driver for
tumor growth, is overexpressed by both RS and SIPS
fibroblasts [8]. Concise network constructed using Short-
est Path function in Pathway Studio software (Fig. 3)
highlighted Iroquois Homeobox 2 (IRX2) and POU4F1
were highlighted as most likely signaling events to connect
the DEGs identified by GeneXPlain-guided microarray
analysis and osteopontin. In this network, suppression of
Aurora kinases that normally monitor the mitotic check-
point, centrosome separation and cytokinesis, cause
catastrophic consequences and result in increase in apop-
tosis, thus, being in in agreement with recently published
observations of senescent fibroblasts [37]. Apoptosis acti-
vated caspase-3 directly or indirectly eliminates POU4F1/
Brn-3a, the prediction that is consistent with previous
observation of enhanced apoptosis in the neurons derived
from Brn-3a knockout mice [38]. Moreover, POU4F1 gene
is expressed in fibroblasts where it is required for prolifer-
ation, and cooperates with activated RAS/RAF signalling
by reducing oncogene-induced senescence, consistent
with its caspase-driven downregulation in both RS and
SIPS [39]. In our network, POU4F1/Brn-3a suppresses
transcription factor IRX2 that repeatedly showed up in
lists of TF that recognize bindings sites differentially
enriched in promoters of genes associated with fibroblast
senescence. Caspase-3-driven removal of POU4F1 allows
higher levels of IRX2 biosynthesis that is known for its
ability to upregulate VEGF, metalloproteinases and other
secreted molecules [40, 41].
An involvement of IRX2 in the transcription of
osteopontin-encoding SPP1 gene was never evaluated in
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wet lab experiments; however, the knowledge-based
algorithm identified IRX2 as positive regulator of SPP1
expression by three independent molecular interaction
events involving AKT1, VEGFA and INS. Moreover,
marker co-expression pattern of IRX2 and SPP1 was
observed during hair-cell development in the chick’s
cochlea [42]. Two independent studies demonstrated
that an expression of IRX2 is commonly suppressed by
DNA methylation of its promoter [43, 44], including its
differential methylation noted in osteoarthritis and
osteoporosis [45], two age-related diseases of the cartil-
age and the bone charactrized by changes in the levels
of osteopontin secretion [46, 47]. As IRX2 is strongly
expression in human primary osteoblasts of the skeleton
[48], its putative roles in SPP1 regulation in osteoarth-
ritis and osteoporosis are worthy of investigation.
Importanttly, Pazolli and co-authors followed up on
their own study that identified osteopontin as driver of
tumor cell proliferation supplied by senescent stromal fi-
broblasts [8] and showed that the treatment with histone
deacetylase (HDAC) inhibitors that reverse CpG methy-
lation is sufficient to induce expression of osteopontin
[49]. Moreover, an examination of PWM matches in the
promoter of SPP1 showed that it contains 25 sites for
IRX2 binding within 1100 nucleotides located between
positions −1000 to +100 relative to major transcription
start site (TSS) for SPP1 gene (Additional file 8).
All this evidence adds up in favor of the hypothesis
that SPP1/osteopontin expression may be controlled by
IRX2, and that its derepression in senescent fibroblast
aids in SIPS-dependent stromal activation that, in turn,
stimulate the growth of tumor cells.
Conclusions
Here we present a detailed comparison of stress/bleo-
mycin induced and replicative senescence. We predicted
the master regulatory molecules and transcription
factors which play a key role in these two types of cell
senescence, RS and SIPS. We showed that SIPS proceeds
in cells that are actively fighting stress which facilitates
premature senescence while failing to completely acti-
vate the orderly program of RS. Stromelysin/MMP3 and
MGAT1 were identified as master regulators of RS and
SIPS, respectively. We also demonstrated that promoters
of genes differentially expressed in either RS or SIPS are
unusually enriched by the binding sites for homeobox
family proteins. Moreover, Iroquois Homeobox 2 (IRX2)
was highlighted as a master regulator for the secretion
of SPP1-encoded osteopontin, a stromal driver for tumor
growth that is overexpressed by both RS and SIPS
fibroblasts. The latter supports the hypothesis that
senescence-specific de-repression of SPP1 aids in SIPS-
dependent stromal activation.
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